Condition

Levodopa (3)

Cognitive Decline (1)

Depressive Disorder, Treatment-Resistant (1)

Dyskinesia, Drug-Induced (1)

Gait Impairment (1)

Late Life Depression (1)

Parkinson Disease (1)

Parkinson's Disease (1)

Overall Status

Completed (2)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

n/a (1)

Sponsor

Novartis Pharmaceuticals (1)

Vanderbilt University Medical Center (1)

Virginia Commonwealth University (1)

Collaborator

Columbia University (1)

Emory University (1)

Intervention

placebo (2)

afq056 (1)

erythromycin (1)

l-dopa (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

levodopa

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Late Life Depression, Cognitive Decline, Depressive Disorder, Treatment-Resistant Trial in Nashville (L-Dopa, Placebo)

Recruiting

Late Life Depression
+4 more

L-Dopa
Placebo

Nashville, Tennessee

Vanderbilt Psychiatric Hospital

Feb 23, 2022

Parkinson Disease, Dyskinesia, Drug-Induced, Levodopa Trial in Worldwide (AFQ056)

Completed

Parkinson Disease
+2 more

AFQ056

Sunnyvale, California
+21 more

Dec 15, 2020

Parkinson's Disease, Levodopa Trial in Richmond (Erythromycin, )

Completed

Has Results

Parkinson's Disease
Levodopa

Erythromycin
placebo

Richmond, Virginia

Virginia Commonwealth University Parkinson's Center

Dec 15, 2016